PDF) Anticoagulation in the cirrhotic patient
Non-uniformity of Changes in Drug-Metabolizing Enzymes and Transporters in Liver Cirrhosis: Implications for Drug Dosage Adjustment | Molecular Pharmaceutics
PDF) Oral Anticoagulation in Patients With Liver Disease
Ultraporous Polyquaternium-Carboxylated Chitosan Composite Hydrogel Spheres with Anticoagulant, Antibacterial, and Rapid Endotoxin Removal Profiles for Sepsis Treatment | Biomacromolecules
Oral Anticoagulation in Patients With Liver Disease - ScienceDirect
Landscape and Dynamics of Single Immune Cells in Hepatocellular Carcinoma - ScienceDirect
PDF) Anticoagulant therapy in patients with liver cirrhosis and portal vein thrombosis: insights for the clinician
Frontiers | Potential Effects of Coronaviruses on the Liver: An Update
PDF) Oral Anticoagulation in Patients With Liver Disease
Nutrients | Free Full-Text | New Perspectives on the Effect of Dandelion, Its Food Products and Other Preparations on the Cardiovascular System and Its Diseases | HTML
Hepatic Vasculopathy and Regenerative Responses of the Liver in Fatal Cases of COVID-19 - Clinical Gastroenterology and Hepatology
Anticoagulation in chronic liver disease - Journal of Hepatology
Anticoagulation in Concomitant Chronic Kidney Disease and Atrial Fibrillation: JACC Review Topic of the Week - ScienceDirect
Assembly and Function of a Bioengineered Human Liver for Transplantation Generated Solely from Induced Pluripotent Stem Cells - ScienceDirect
Cells | Free Full-Text | Pathophysiology and Treatment Options for Hepatic Fibrosis: Can It Be Completely Cured? | HTML
Oral Anticoagulation in Patients With Liver Disease - ScienceDirect
Liver Cirrhosis in Patients With Atrial Fibrillation: Would Oral Anticoagulation Have a Net Clinical Benefit for Stroke Prevention? | Journal of the American Heart Association
A Systematic Review of Prophylactic Anticoagulation in Nephrotic Syndrome - ScienceDirect
Liver Cirrhosis in Patients With Atrial Fibrillation: Would Oral Anticoagulation Have a Net Clinical Benefit for Stroke Prevention? | Journal of the American Heart Association
Frontiers | Drug-Induced Liver Injury: Biomarkers, Requirements, Candidates, and Validation
Frontiers | Novel Anti-inflammatory Treatments in Cirrhosis. A Literature-Based Study
Oral Anticoagulation in Patients With Liver Disease - ScienceDirect
Page 192 - Ghidul Serviciilor Medicale Synevo, Ediția 2, Volum 2
Grand Round: Anticoagulation in Chronic Liver Disease
S100A11 Promotes Liver Steatosis via FOXO1-Mediated Autophagy and Lipogenesis - Cellular and Molecular Gastroenterology and Hepatology
Anticoagulants and Transaminase Elevation | Circulation
Resistance to thrombomodulin correlates with liver stiffness in chronic liver disease a prospective single-center cohort study - Thrombosis Research
Anticoagulation in the cirrhotic patient - ScienceDirect
Current and novel biomarkers of thrombotic risk in COVID-19: a Consensus Statement from the International COVID-19 Thrombosis Biomarkers Colloquium | Nature Reviews Cardiology
